Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor
暂无分享,去创建一个
H. Janssen | H. Reesink | R. Molenkamp | J. Schinkel | C. Weegink | H. Reesink | E. Hughes | X. Thomas | J. Bruijne | R. J. Knegt | J. Bergmann | M. Treitel | S. Rebers | S. Rebers | H. Janssen | R. J. Knegt